Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New diabetes pill studied in real life: does it lower blood sugar?

NCT ID NCT04601740

First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 27 times

Summary

This study looked at how well the diabetes pill Rybelsus (oral semaglutide) works in real-world settings for adults with type 2 diabetes. Researchers tracked changes in blood sugar levels and body weight over about 8-10 months. Participants took the medication as prescribed by their doctor and filled out questionnaires during regular visits. The goal was to see if the pill helps control diabetes in everyday conditions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Master Centre Netherlands

    Alphen aan den Rijn, 2408 AV, Netherlands

Conditions

Explore the condition pages connected to this study.